VIASPACE (VSPC) 10-Q 19 Nov 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2018	Nov. 19, 2018
Document And Entity Information [Abstract]
Entity Registrant Name	VIASPACE Inc.
Entity Central Index Key	1,270,200
Document Type	10-Q
Trading Symbol	VSPC
Document Period End Date	Sep. 30, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		3,889,878,192
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,018
Entity Small Business	true
Entity Emerging Growth Company	false

BALANCE SHEETS (Unaudited)

BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
CURRENT ASSETS:
Cash and cash equivalents	$ 7,000	$ 4,000
Accounts Receivable	35,000
Accounts Receivable - Related Parties	2,000	0
Prepaid expenses	19,000	22,000
TOTAL CURRENT ASSETS	63,000	26,000
OTHER ASSETS:
Investments	0	6,000
Other assets	1,000	1,000
TOTAL OTHER ASSETS	1,000	7,000
TOTAL ASSETS	64,000	33,000
CURRENT LIABILITIES:
Accounts payable	89,000	83,000
Accounts Payable - Related Party	29,000	16,000
Accrued expenses	19,000	18,000
Unearned revenue	26,000	20,000
Related party payables	749,000	749,000
TOTAL CURRENT LIABILITIES	912,000	886,000
COMMITMENTS AND CONTINGENCIES (Note 10)
SHAREHOLDERS’ DEFICIT:
Preferred stock, $0.0001 par value in 2018 and 2017, 10,000,000 shares authorized, one share of Series A preferred stock issued and outstanding as of September 30, 2018 and December 31, 2017	0	0
Common stock, $0.0001 par value in 2018 and 2017, 8,000,000,000 shares authorized, 3,887,958,192 shares issued and 3,787,958,192 shares outstanding as of September 30, 2018, and 3,402,514,447 shares issued and 3,302,514,447 shares outstanding as of December 31, 2017	379,000	330,000
Additional paid in capital	53,724,000	53,136,000
Accumulated deficit	(54,951,000)	(54,319,000)
Total shareholders’ deficit	(848,000)	(853,000)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 64,000	$ 33,000

BALANCE SHEETS (Unaudited) (Par

BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2018	Dec. 31, 2017
Statement Of Financial Position [Abstract]
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	1	1
Preferred stock, shares outstanding	1	1
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	8,000,000,000	8,000,000,000
Common stock, shares issued	3,887,958,192	3,402,514,447
Common stock, shares outstanding	3,787,958,192	3,302,514,447

STATEMENTS OF OPERATIONS (Unaud

STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
REVENUES	$ 73,000	$ 33,000	$ 98,000	$ 101,000
COST OF REVENUES	0	2,000	13,000	16,000
GROSS PROFIT	73,000	31,000	85,000	85,000
OPERATING EXPENSES
Operations	0	8,000	29,000	29,000
Selling, general and administrative	507,000	267,000	598,000	703,000
Total operating expenses	507,000	275,000	627,000	732,000
LOSS FROM OPERATIONS	(434,000)	(244,000)	(542,000)	(647,000)
OTHER INCOME (EXPENSE)
Interest expense	(14,000)	(48,000)	(84,000)	(141,000)
Other expense	(3,000)	(2,000)	(6,000)	(8,000)
Total other income (expense)	(17,000)	(50,000)	(90,000)	(149,000)
LOSS BEFORE INCOME TAXES	(451,000)	(294,000)	(632,000)	(796,000)
INCOME TAXES	0	0	0	0
NET LOSS	$ (451,000)	$ (294,000)	$ (632,000)	$ (796,000)
LOSS PER SHARE OF COMMON STOCK – Basic and diluted	$ 0	$ 0	$ 0	$ 0
WEIGHTED AVERAGE SHARES OUTSTANDING – Basic and diluted	3,860,988,342	3,237,284,099	3,677,586,487	3,051,228,069

STATEMENTS OF CASH FLOWS (Unaud

STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (632,000)	$ (796,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock option and stock compensation	467,000	317,000
Stock issued for consulting expense	3,000	52,000
Amortization of discounts on notes payable	84,000	139,000
Loss on minority investment in Almaden Energy Group	6,000	8,000
(Increase) decrease in operating assets:
Accounts receivable	(35,000)	0
Accounts receivable - Related Party	(2,000)	0
Prepaid expenses and other assets	3,000	1,000
Increase (decrease) in operating liabilities:
Accounts payable	6,000	25,000
Accounts Payable - Related Party	13,000	0
Accrued expenses and other	7,000	(7,000)
Related party Payable	0	109,000
Net cash used in operating activities	(80,000)	(152,000)
CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in investing activities	0	0
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable- related party	83,000	139,000
Stock issued for investment by non-related parties	0	5,000
Net cash provided by financing activities	83,000	144,000
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	3,000	(8,000)
CASH AND CASH EQUIVALENTS, Beginning of period	4,000	19,000
CASH AND CASH EQUIVALENTS, End of period	7,000	11,000
Cash paid during the period for:
Interest	0	0
Income taxes	$ 0	$ 0
Supplemental Disclosure on Non-Cash Activities
Common stock issued for future funding source, shares	100,000,000	100,000,000
Common stock issued for future services, shares		50,000,000
Common stock issued for future services, value		$ 75,000
Discount on loans from beneficial conversion feature	$ 83,000	139,000
Convertible loans converted to equity	$ 83,000	$ 139,000

1. SUMMARY OF SIGNIFICANT ACCOU

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business – VIASPACE Inc. (“we”, “us”, “VIASPACE”, or the “Company”) was founded in July 1998. Its business involves renewable energy and is based on biomass, in particular our license to a dedicated energy crop with the trademark “Giant King ® GKG can be burned in 100% biomass power plants to generate electricity; made into pellets that can be burned together with coal to reduce carbon emissions from existing power plants; generate bio methane through anaerobic digestion, and can be used as a feedstock for low carbon liquid biofuels for transportation, biochemicals and bio plastics. Cellulosic ethanol, bio butanol and other liquid cellulosic biofuels, do not use corn or other food sources as feedstock. GKG can also be used as animal feed. GKG and other plants absorb and store carbon dioxide from the atmosphere as they grow. When they are burned, they release the carbon dioxide back into the atmosphere, but it is the same carbon dioxide that was removed from the atmosphere, and so this process is carbon neutral. Small amounts of fossil fuel are used by the farm equipment, transportation of GKG and fertilizer, so that the overall process of growing and burning GKG probably has some net carbon dioxide emissions, but much lower emissions than burning coal or other fossil fuels directly to create the same amount of energy. GKG has been independently tested by customers and been shown to have excellent energy content, high bio methane production, and the cellulosic sugar content needed for biofuels and biochemicals. Going Concern – We have incurred significant losses from operations, resulting in an accumulated deficit of $54,951,000. We expect such losses to continue. However, on November 30, 2016, we entered into a Loan Agreement with Vice Chairman Haris Basit whereby he agreed to fund us $100,000 over a two-year period. In addition, on February 23, 2017, we entered into a Loan Agreement with CEO Kevin Schewe whereby he agreed to fund us $100,000 over a two-year period. After completing funding of this loan we entered into a new Loan Agreement with Dr. Schewe on May 24, 2018 whereby he agreed to fund us $100,000 over a two-year period. In addition, on July 25, 2017, we entered into a Loan Agreement with CTO Carl Kukkonen whereby he agreed to fund us $25,000 over a two-year period. We expect loans from Mr. Basit, Dr. Schewe and Dr. Kukkonen and revenue generated from future contracts using the license we have for Giant King Grass to fund operations for the foreseeable future. However, no assurance can be given that Mr. Basit, Dr. Schewe or Dr. Kukkonen will continue to fund us or that sales contracts will be obtained in the future, or if they are obtained, that they will be profitable. Accordingly, there continues to be substantial doubt as to our ability to continue as a going concern. The financial statements do not include any other adjustments that might result from the outcome of these uncertainties. Basis of Presentation – The unaudited interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2017 and notes thereto included in our annual report on Form 10-K. We follow the same accounting policies in the preparation of interim reports. Results of operations for the interim periods are not indicative of annual results. Recent Accounting Standards – The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-07 to simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance expands the scope of Accounting Standards Codification (ASC) 718 to include share-based payments granted to nonemployees in exchange for goods or services used or consumed in an entity’s own operations and supersedes the guidance in ASC 505-50. The FASB launched the project in response to requests it received in its post-implementation review of Statement No. 123(R), Share-Based Payment. The ASU aligns much of the guidance on measuring and classifying nonemployee awards with that of awards to employees. The key changes from ASC 505-50 are: • Equity-classified nonemployee awards are measured on the grant date, rather than on the earlier of (1) the performance commitment date or (2) the date at which the nonemployee’s performance is complete. • Awards to nonemployees are measured by estimating the fair value of the equity instruments to be issued, rather than the fair value of the goods or services received or the fair value of the equity instruments issued, whichever can be measured more reliably. • During the vesting period, nonemployee awards that contain a performance condition that affects the quantity or other terms (e.g., exercise price) of the award are measured based on the outcome that is probable. This differs from the guidance in ASC 505-50 that requires these types of awards to be measured at the lowest aggregate fair value within a range of possible outcomes. • Entities may use the expected term to measure nonemployee awards or elect to use the contractual term as the expected term, on an award-by-award basis. This differs from the guidance in ASC 505-50 that requires the use of the contractual term. Public entities must adopt the new standard in the fiscal year beginning on 12/15/2018. Companies can early adopt the new standard but are required to adopt ASC Topic 606 alongside their adoption of ASU 2018-07. We adopted the standard utilizing the modified retrospective adoption method. The adoption of this guidance does not have a material impact on our financial statements. In May 2014, FASB and the International Accounting Standards Board jointly issued a new revenue recognition standard that is designed to improve financial reporting by creating common recognition guidance for U.S. GAAP and International Financial Reporting Standards. The new guidance issued under Accounting Standards Update (" ASU 2014-09 Revenue from Contracts with Customers Topic 606 ASU 2014-09 In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. The adoption of this guidance does not have a material impact on our financial statements.

2. PREPAID EXPENSES

2. PREPAID EXPENSES	9 Months Ended
	Sep. 30, 2018
Prepaid Expense And Other Assets Current [Abstract]
PREPAID EXPENSES	NOTE 2 – PREPAID EXPENSES We entered into agreements with certain of its consultants and vendors whereby we issued unregistered shares of common stock in exchange for services to be provided to us. We engaged a third-party provider to pay certain of our expenses on our behalf. As compensation for the payment of these expenses on our behalf, we pay the provider in shares of common stock equivalent to the expense paid plus a fee equal to 15% of the expense paid. As of September 30, 2018 and December 31, 2017, included in prepaid expenses for this third-party provider is $19,000 and $22,000, respectively, for shares of stock issued to the provider in excess of amounts paid on our behalf. Other prepaid expenses (non-stock related) were $0 and $0 at September 30, 2018 and December 31, 2017, respectively.

3. REVENUES

3. REVENUES	9 Months Ended
	Sep. 30, 2018
Revenues [Abstract]
REVENUES	NOTE 3 – REVENUES Adoption of ASC Topic 606, "Revenue from Contracts with Customers" On January 1, 2018, we adopted Topic 606 using the modified retrospective method applied to those contracts which were not completed as of January 1, 2018. Results for reporting periods beginning after January 1, 2018 are presented under Topic 606, while prior period amounts are not adjusted and continue to be reported in accordance with our historic accounting under Topic 605. We did not have a cumulative impact as of January 1, 2018 due to the adoption of Topic 606 and there was not an impact to our statement of operations for the nine months ended September 30, 2018 as a result of applying Topic 606.

4. STOCK OPTIONS

4. STOCK OPTIONS	9 Months Ended
	Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
STOCK OPTIONS	Note 4 – STOCK OPTIONS The fair value of each stock option granted is estimated on the date of the grant using the Black-Scholes option pricing model. The Black-Scholes option pricing model has assumptions for risk free interest rates, dividends, stock volatility and expected life of an option grant. The risk free interest rate is based upon market yields for United States Treasury debt securities at a maturity near the term remaining on the option. Dividend rates are based on the Company’s dividend history. The stock volatility factor is based on the historical volatility of the Company’s stock price. The expected life of an option grant is based on management’s estimate as no options have been exercised in the Plan to date. The Company calculated a forfeiture rate for employees and directors based on historical information. A forfeiture rate of 0% is used for options granted to consultants. The fair value of each option grant to employees, directors and consultants is calculated by the Black-Scholes method and is recognized as compensation expense on a straight-line basis over the vesting period of each stock option award. The risk-free interest rate for the period within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of the grant. 2018 Dividends 0% Volatility factor 156% Expected life 10 years Annual forfeiture rate 0% The following is a summary of the Company’s stock option activity for the nine months ended at September 30, 2018: Number of Shares Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term In Years Aggregate Intrinsic Value Outstanding at December 31, 2017 449,480,441 $ 0.0026 8.28 Granted 1,455,000,000 $ 0.0008 9.84 Exercised — — Cancelled and forfeited — — Outstanding at September 30, 2018 1,904,480,441 $ 0.0012 9.29 $ — Exercisable at September 30, 2018 1,176,980,441 $ 0.0015 9.29 $ — Stock options totalling 1,455,000,000 were granted during the nine months ended September 30, 2018. The Plan recorded $467,000 of compensation expense for employees and director stock options in 2018. At September 30, 2018, there was $394,731 of unrecognized compensation costs related to non-vested share-based compensation arrangements under the Plan that is expected to be recognized over a weighted average period of approximately two year. There were no options exercised during the nine months ended September 30, 2018.

5. INVESTMENTS

5. INVESTMENTS	9 Months Ended
	Sep. 30, 2018
Equity Method Investments And Joint Ventures [Abstract]
INVESTMENTS	Note 5 – Investments O ur 18.75% ownership interest in Almaden Energy Group, LLC (“AEG”), which became effective April 15, 2015, was sold July 16, 2018 to CMAC Agriculture, LLC (“CMAC”) and we received 3.375% ownership interest in CMAC in return. The sale included all AEG assets, intellectual property, and the license agreement with our company. The Giant King Grass supply contract with Almaden Energy Group, LLC. (“AEG”) we entered into on April 13, 2015 included a license to grow Giant King Grass only for animal feed, nursery and research purposes anywhere within the 48 contiguous United States. AEG was permitted to sell Giant King Grass anywhere in the world with the exception of the State of Hawaii. The CEO of AEG is also the former CEO and current member of the Board of Directors of the Company. We also own an 18.75% interest in Viaspace California, Inc (“VSCA”), a company formed on March 1, 2018. VSCA is developing a business related to Cannabidiol (“CBD”), a cannabis compound that has significant medical benefits. The method of accounting for the investment is the equity method because a shareholder and controlling shareholder, both directors of Viaspace, along with the company collectively, has more than 50% control of Viaspace California. Dividends are recognized in income when declared and totaled $0 for the period ending September 30, 2018. The carrying value of the investment is $0 as of September 30, 2018. On June 1, 2017, we acquired a 2.91% interest in Clean Energy Solutions, LLC’s (“CES”) outstanding membership interest units. We have accounted for this investment by the cost method because the membership interest units of that company are unlisted and the criteria for using the equity method of accounting are not satisfied as we are not able to exercise significant influence over CES. CES is a customer of the Company who is in discussion for future GKG contracts. At September 30, 2018, our interest in CES is recorded at $0.

6. CONVERTIBLE NOTES PAYABLE TO

6. CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES	9 Months Ended
	Sep. 30, 2018
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES	NOTE 6 – CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES Loan Agreement with Haris Basit Effective November 30, 2016, we entered into a Loan Agreement with Director Haris Basit whereby Mr. Basit agreed to loan up to $100,000 to us over a two-year period based on requests from the Company. Each individual loan will accrue interest at 8% per annum. Each note would mature on the first anniversary of the issuance date of such note. Each note is convertible at Mr. Basit’s request, into a fixed number of shares of our common stock based on the closing price of our common stock for the twenty trading days prior to the issuance of the loan, less an 80% discount. The Loan Agreement states that Mr. Basit will not convert any loan into a number of shares that would exceed the number of available authorized common shares calculated as of the date of the conversion. As a result, the conversion feature is not deemed to be a derivative instrument subject to bifurcation. During the nine months ended September 30, 2018, Mr. Basit made loans of $27,500 to us. We recorded a discount on the loans of $27,500 as a result of a beneficial conversion feature, which will be amortized over the term of the note on a straight-line basis, which approximates the effective interest method. During 2018, Mr. Basit converted loans totalling $27,500 into 127,691,910 common shares of the Company. At the time of the conversions, we recorded the discount as additional interest expense. There are $0 loans outstanding at September 30, 2018. As of September 30, 2018, we had no remaining availability under the note. Loan Agreement with Kevin Schewe Effective February 23, 2017, we entered into a Loan Agreement with CEO Kevin Schewe whereby Dr. Schewe agreed to loan up to $100,000 to us over a two-year period based on requests from the Company. Each individual loan will accrue interest at 8% per annum. Each note would mature on the first anniversary of the issuance date of such note. Each note is convertible at Dr. Schewe’s request, into a fixed number of shares of our common stock based on the closing price of our common stock for the twenty trading days prior to the issuance of the loan, less an 80% discount. The Loan Agreement states that Dr. Schewe will not convert any loan into a number of shares that would exceed the number of available authorized common shares calculated as of the date of the conversion. As a result, the conversion feature is not deemed to be a derivative instrument subject to bifurcation. Effective May 24, 2018, we entered into a new Loan Agreement with CEO Kevin Schewe whereby Dr. Schewe agreed to loan up to $100,000 to us over a two-year period based on requests from the Company. Each individual loan will accrue interest at 8% per annum. Each note would mature on the first anniversary of the issuance date of such note. Each note is convertible at Dr. Schewe’s request, into a fixed number of shares of our common stock based on the closing price of our common stock for the twenty trading days prior to the issuance of the loan, less an 80% discount. This Loan Agreement also states that Dr. Schewe will not convert any loan into a number of shares that would exceed the number of available authorized common shares calculated as of the date of the conversion. As a result, the conversion feature is not deemed to be a derivative instrument subject to bifurcation. During the nine months ended September 30, 2018, Dr. Schewe made loans of $56,000 to us. We recorded a discount on the loans of $56,000 as a result of a beneficial conversion feature, which will be amortized over the term of the note on a straight-line basis, which approximates the effective interest method. During 2018, Dr. Schewe converted loans totalling $56,000 into 353,351,835 common shares of the Company. At the time of the conversions, we recorded the discount as additional interest expense. There are $0 loans outstanding at September 30, 2018. As of September 30, 2018, we had $64,000 remaining availability under the new note. Loan Agreement with Carl Kukkonen Effective July 25, 2017, we entered into a Loan Agreement with CTO Carl Kukkonen whereby Dr. Kukkonen agreed to loan up to $25,000 to us over a two-year period based on requests from the Company. Each individual loan will accrue interest at 8% per annum. Each note would mature on the first anniversary of the issuance date of such note. Each note is convertible at Dr. Kukkonen’s request, into a fixed number of shares of our common stock based on the closing price of our common stock for the twenty trading days prior to the issuance of the loan, less an 80% discount. The Loan Agreement states that Dr. Kukkonen will not convert any loan into a number of shares that would exceed the number of available authorized common shares calculated as of the date of the conversion. As a result, the conversion feature is not deemed to be a derivative instrument subject to bifurcation. During the nine months ended September 30, 2018, Dr. Kukkonen made loans of $0 to the Company and there are $0 loans outstanding at September 30, 2018. As of September 30, 2018, the Company had remaining availability under the note of $13,500.

7. STOCKHOLDERS' EQUITY

7. STOCKHOLDERS' EQUITY	9 Months Ended
	Sep. 30, 2018
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 7 – STOCKHOLDERS’ EQUITY Preferred Stock At September 30, 2018 and December 31, 2017, the number of authorized shares of our preferred stock was 10,000,000. The par value of the preferred stock is $0.0001. At September 30, 2018 and December 31, 2017, there is one share of Series A Preferred Stock outstanding. Common Stock As of January 1, 2018, the number of authorized shares of our common stock was 3,900,000,000. As of June 30, 2018 the number of authorized shares was increased to 8,000,000,000. The par value of the common stock is $0.0001. During the 9 months ended September 30, 2017, we issued 50,000,000 unregistered restricted shares of common stock respectively to a funding source so that the funding source can pay for future expenses on our behalf. The shares are issued to the funding source to cover the amount of future expenses plus a fee of 15% of such future expenses. At the time of the future payment of the expenses incurred by us, the common stock and additional paid in capital are credited for the amount of the future payment plus 15%. During the period ending September 30, 2018, there is no accounting impact from this transaction because the shares remain in our possession. During 2018, we issued 4,400,000 shares of common stock to a consultant of the Company. The shares were issued at fair market value of approximately $3,000 on the date of the issuance. During 2018, we issued 353,351,835 shares of common stock to CEO Kevin Schewe as he converted loans into shares of common stock as allowed under an agreement he has with us as discussed in Note 5. During 2018, we issued 127,691,910 shares of common stock to Director Haris Basit as he converted loans into shares of common stock as allowed under an agreement he has with us as discussed in Note 5. As of September 30, 2018, there were 3,887,958,192 shares of common stock issued and 3,787,958,192 shares of common stock outstanding.

8. NET LOSS PER SHARE

8. NET LOSS PER SHARE	9 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
NET LOSS PER SHARE	NOTE 8 – NET LOSS PER SHARE We compute net loss per share in accordance with FASB ASC Topic 260. Under its provisions, basic loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted earnings would customarily include, if dilutive, potential shares of common stock issuable upon the exercise of stock options and warrants. The dilutive effect of outstanding stock options and warrants is reflected in earnings per share in accordance with FASB ASC Topic 260 by application of the treasury stock method. For the periods presented, the computation of diluted loss per share was equal to basic loss per share as the inclusion of any dilutive instruments would have had an antidilutive effect on the earnings per share calculation in the periods presented. The following table sets forth common stock equivalents (potential common stock) at September 30, 2018 and 2017 that are not included in the loss per share calculation since their effect would be anti-dilutive for the periods indicated: 2018 2017 Stock Options 1,904,480,441 418,855,000 The following table sets forth the computation of basic and diluted net loss per share for 2018 and 2017, respectively: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Basic and diluted net loss per share: Numerator: Net loss attributable to common stock $ (451,000 ) $ (294,000 ) $ (632,000 ) $ (796,000 ) Denominator: Weighted average shares of common stock outstanding 3,860,988,342 3,237,284,099 3,677,586,487 3,051,228,069 Net loss per share of common stock, basic and diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00

9. RELATED PARTY TRANSACTIONS

9. RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2018
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Included in our balance sheets at September 30, 2018 and December 31, 2017 are Related Party Receivables of $2,000 and $0, respectively. We have a receivable of $2,000 at September 30, 2018 due from Viaspace California, Inc., which represents start-up costs for the new entity. Also included in our balance sheets at September 30, 2018 and December 31, 2017 are Related Party Payables of $749,000 and $749,000, respectively. We have a payable of $689,000 and $689,000, at September 30, 2018 and December 31, 2017 owed to Dr. Carl Kukkonen, CTO. Of the amount owed to Dr. Kukkonen, there is a cash component totalling $185,000 and a common stock component totalling $504,000. Dr. Kukkonen deferred a portion of his 2009, 2010 and 2011 stock awards and is entitled to the following unregistered shares of our common stock at September 30, 2018: 11,195,707 shares for deferred 2009 compensation; 8,467,939 shares for deferred 2010 compensation; and 24,730,678 shares for deferred 2011 compensation. We also owe Director Haris Basit $60,000 at September 30, 2018, representing salary earned but not paid. In addition, at September 30, 2018 there are Other Related Party Payables owed to Dr. Kukkonen, in the amount of $2,000, to Mr. Basit, in the amount of $18,000 and to Mr. Nicholas Stoll, in the amount of $9,000. Also, Mr. Basit was granted 37,500,000 options at September 30, 2017, and 500,000,000 options at September 30, 2018. During the nine months ended September 30 2018 the Company granted Dr. Kevin Schewe, Dr. Carl Kukkonen, Mr. Nick Stoll and Ms. Angelina Galiteva 350,000,000, 150,000,000, 100,000,000 and 10,000,000 options, respectively. See Note 4 for valuations of the stock options. We have a loan agreement with CEO Dr. Kevin Schewe, Director Haris Basit and CTO Carl Kukkonen which is described in Note 6.

10. COMMITMENTS AND CONTINGENCI

10. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2018
Commitments And Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 10 – COMMITMENTS AND CONTINGENCIES Leases We currently have no long term office lease. We terminated the lease on land in San Diego County, California on August 31, 2017, where we grew Giant King Grass. Rent and utility expense charged to operations for the three months ended September 30, 2018 and 2017, was $0 and $4,000, respectively. Rent and utility expense charged to operations for the nine months ended September 30, 2018 and 2017 was $0 and $9,000, respectively. Collaborative Agreements We are a party to certain collaborative agreements with various entities for the joint operation of test plots to establish that GKG grows well in the area and optimal agronomic practices are developed. These agreements are in the form of development collaborations and licensing agreements. Under these agreements, we have granted rights to grow and use of GKG. In return, we are entitled to receive certain payments for the operations of the test plots and license fees on the harvesting of GKG should it ultimately be commercialized. All of our collaborative agreements are subject to termination by either party, without significant financial penalty. Under the terms of these agreements, upon a termination we are entitled to reacquire all rights in our technology at no cost and are free to re-license the technology to other collaborative partners. Revenue earned from collaborative agreements is comprised of negotiated payments for the establishment, evaluation and operations of GKG test plots. Deferred revenue represents customer payments received which are related to future performance. Generally, for collaborative agreements establishing test plots, we recognize revenue only after the Giant King Grass is planted in the customer’s location. Until that time any money received is recorded as deferred revenue. During the three months ended September 30, 2018 and 2017, we received $0 and $0 payments under these collaborative agreements. During the nine months ended September 30, 2018 and 2017 we received $20,000 and $0, respectively, in payments under these collaborative agreements. We recognized revenue from these collaborative agreements of $13,846 and $0 for the nine months ended September 30, 2018 and 2017. Global Supply, License, and Commercialization Agreement Executed on April 4, 2016 and effective as of March 28, 2016, the Company, VGE and Guangzhou Inter-Pacific Arts Corp., a Chinese wholly-owned foreign enterprise registered in Guangdong province ("IPA") owned by VGE, entered into the Global Supply, License, and Commercialization Agreement (the "New Agreement"). Prior to the New Agreement, IPA and VGE had entered into a certain Supply and Commercialization Agreement dated September 30, 2012 regarding a license and supply arrangement between IPA and VGE regarding Giant King Grass ("IPA-VGE Agreement"). In turn, VGE and the Company also entered into a certain Supply and Commercialization Agreement dated September 30, 2012 regarding a license and supply arrangement between VGE and the Company regarding Giant King Grass ("VGE-VIASPACE Agreement"). Under the New Agreement, VGE and the Company terminated the VGE-VIASPACE Agreement and IPA directly granted the Company an exclusive, perpetual license to commercialize its intellectual property rights to three (3) types of high yield, non-genetically modified grasses ("Three GK Grasses") throughout the world except Cambodia, People’s Republic of China, Taiwan, Thailand, Myanmar, Malaysia, Laos, Vietnam and Singapore ("VIASPACE Territory"). It and VGE agreed to subordinate the terms of the IPA-VGE Agreement to the terms of the New Agreement. IPA also granted the right to use and market the name "Giant King Grass" and other related names. The Company would owe royalty payments on the Net Sales of the Three GK Grasses. This license would be sublicenseable in the VIASPACE Territory. IPA held all rights of ownership to the Three GK Grasses. The Company would own any grasses resulting from any modifications or improvements to the Three GK Grasses. IPA would use commercially reasonable efforts to maintain its intellectual property rights. The Company would use commercially reasonable efforts to commercialize the Three GK Grasses throughout the VIASPACE Territory. Employment Agreements On July 25, 2017, the Company announced that effective July 31, 2017, Haris Basit resigned as CEO of the Company to move to a position leading a Silicon Valley based technology company. Mr. Basit became Vice-Chairman of the Company’s Board of Directors and thus continues to be involved in the overall strategic direction of the Company. During this transition of leadership, Dr. Kevin Schewe, who is the largest shareholder of the Company and Board Chairman, became the acting CEO. Litigation The Company is not party to any material legal proceedings at the present time.

11. SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS On October 22, 2018, we issued 1,960,000 shares of our common stock to a consultant. The shares were issued at fair market value of approximately $1,000 on the date of the issuance. On October 15, 2018, the Company announced that effective October 9, 2018, Dr. Carl Kukkonen resigned as CTO and as Director of the Board of the Company. Dr. Kukkonen continues as a consultant to the Company and the position of CTO remains vacant.

1. SUMMARY OF SIGNIFICANT ACC_2

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2018
Accounting Policies [Abstract]
Going Concern	Going Concern – We have incurred significant losses from operations, resulting in an accumulated deficit of $54,951,000. We expect such losses to continue. However, on November 30, 2016, we entered into a Loan Agreement with Vice Chairman Haris Basit whereby he agreed to fund us $100,000 over a two-year period. In addition, on February 23, 2017, we entered into a Loan Agreement with CEO Kevin Schewe whereby he agreed to fund us $100,000 over a two-year period. After completing funding of this loan we entered into a new Loan Agreement with Dr. Schewe on May 24, 2018 whereby he agreed to fund us $100,000 over a two-year period. In addition, on July 25, 2017, we entered into a Loan Agreement with CTO Carl Kukkonen whereby he agreed to fund us $25,000 over a two-year period. We expect loans from Mr. Basit, Dr. Schewe and Dr. Kukkonen and revenue generated from future contracts using the license we have for Giant King Grass to fund operations for the foreseeable future. However, no assurance can be given that Mr. Basit, Dr. Schewe or Dr. Kukkonen will continue to fund us or that sales contracts will be obtained in the future, or if they are obtained, that they will be profitable. Accordingly, there continues to be substantial doubt as to our ability to continue as a going concern. The financial statements do not include any other adjustments that might result from the outcome of these uncertainties.
Basis of Presentation	Basis of Presentation – The unaudited interim financial statements included herein, presented in accordance with United States generally accepted accounting principles and stated in US dollars, have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for fair presentation of the information contained therein. It is suggested that these interim financial statements be read in conjunction with our financial statements for the year ended December 31, 2017 and notes thereto included in our annual report on Form 10-K. We follow the same accounting policies in the preparation of interim reports. Results of operations for the interim periods are not indicative of annual results.
Recent Accounting Standards	Recent Accounting Standards – The Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2018-07 to simplify the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance expands the scope of Accounting Standards Codification (ASC) 718 to include share-based payments granted to nonemployees in exchange for goods or services used or consumed in an entity’s own operations and supersedes the guidance in ASC 505-50. The FASB launched the project in response to requests it received in its post-implementation review of Statement No. 123(R), Share-Based Payment. The ASU aligns much of the guidance on measuring and classifying nonemployee awards with that of awards to employees. The key changes from ASC 505-50 are: • Equity-classified nonemployee awards are measured on the grant date, rather than on the earlier of (1) the performance commitment date or (2) the date at which the nonemployee’s performance is complete. • Awards to nonemployees are measured by estimating the fair value of the equity instruments to be issued, rather than the fair value of the goods or services received or the fair value of the equity instruments issued, whichever can be measured more reliably. • During the vesting period, nonemployee awards that contain a performance condition that affects the quantity or other terms (e.g., exercise price) of the award are measured based on the outcome that is probable. This differs from the guidance in ASC 505-50 that requires these types of awards to be measured at the lowest aggregate fair value within a range of possible outcomes. • Entities may use the expected term to measure nonemployee awards or elect to use the contractual term as the expected term, on an award-by-award basis. This differs from the guidance in ASC 505-50 that requires the use of the contractual term. Public entities must adopt the new standard in the fiscal year beginning on 12/15/2018. Companies can early adopt the new standard but are required to adopt ASC Topic 606 alongside their adoption of ASU 2018-07. We adopted the standard utilizing the modified retrospective adoption method. The adoption of this guidance does not have a material impact on our financial statements. In May 2014, FASB and the International Accounting Standards Board jointly issued a new revenue recognition standard that is designed to improve financial reporting by creating common recognition guidance for U.S. GAAP and International Financial Reporting Standards. The new guidance issued under Accounting Standards Update (" ASU 2014-09 Revenue from Contracts with Customers Topic 606 ASU 2014-09 In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. The adoption of this guidance does not have a material impact on our financial statements.

4. STOCK OPTIONS (Tables)

4. STOCK OPTIONS (Tables)	9 Months Ended
	Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Fair Value Assumptions	2018 Dividends 0% Volatility factor 156% Expected life 10 years Annual forfeiture rate 0%
Summary of Stock Option Activity	The following is a summary of the Company’s stock option activity for the nine months ended at September 30, 2018: Number of Shares Weighted- Average Exercise Price Per Share Weighted- Average Remaining Contractual Term In Years Aggregate Intrinsic Value Outstanding at December 31, 2017 449,480,441 $ 0.0026 8.28 Granted 1,455,000,000 $ 0.0008 9.84 Exercised — — Cancelled and forfeited — — Outstanding at September 30, 2018 1,904,480,441 $ 0.0012 9.29 $ — Exercisable at September 30, 2018 1,176,980,441 $ 0.0015 9.29 $ —

8. NET LOSS PER SHARE (Tables)

8. NET LOSS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2018
Earnings Per Share [Abstract]
Common Stock Equivalents Not Included in Loss per Share	The following table sets forth common stock equivalents (potential common stock) at September 30, 2018 and 2017 that are not included in the loss per share calculation since their effect would be anti-dilutive for the periods indicated: 2018 2017 Stock Options 1,904,480,441 418,855,000
Computation of basic and diluted net loss per share	The following table sets forth the computation of basic and diluted net loss per share for 2018 and 2017, respectively: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2018 2017 2018 2017 Basic and diluted net loss per share: Numerator: Net loss attributable to common stock $ (451,000 ) $ (294,000 ) $ (632,000 ) $ (796,000 ) Denominator: Weighted average shares of common stock outstanding 3,860,988,342 3,237,284,099 3,677,586,487 3,051,228,069 Net loss per share of common stock, basic and diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00

1. SUMMARY OF SIGNIFICANT ACC_3

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	May 24, 2018	Jul. 25, 2017	Feb. 23, 2017	Nov. 30, 2016	Sep. 30, 2018	Dec. 31, 2017
Accounting Policies [Line Items]
Accumulated deficit					$ 54,951,000	$ 54,319,000
Haris Basit [Member]
Accounting Policies [Line Items]
Debt, face amount				$ 100,000
Debt maturity period				2 years
Dr. Kevin Schewe [Member]
Accounting Policies [Line Items]
Debt, face amount			$ 100,000
Debt maturity period			2 years
Debt, face amount under new loan agreement	$ 100,000
Debt maturity period under new loan agreement	2 years
Dr. Kukkonen [Member]
Accounting Policies [Line Items]
Debt, face amount		$ 25,000
Debt maturity period		2 years
Giant King Grass [Member]
Accounting Policies [Line Items]
Percentage of biomass power to generate electricity					100.00%

2. PREPAID EXPENSES (Details Na

2. PREPAID EXPENSES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Percentage of fee on expense paid to third party provider	15.00%
Prepaid expenses	$ 19,000	$ 22,000
Stock Related Expenses [Member]
Prepaid expenses	19,000	22,000
Non-Stock Related Expenses [Member]
Prepaid expenses	$ 0	$ 0

4. STOCK OPTIONS (Details Narra

4. STOCK OPTIONS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of options exercised	0
Annual forfeiture rate	0.00%
Granted	1,455,000,000
Stock option and stock compensation	$ 467,000	$ 317,000
Unrecognized compensation costs related to non-vested shares	$ 394,731
Weighted average period of unrecognized compensation cost related to non-vested shares, expected to be recognized	2 years

4. STOCK OPTIONS (Details - Ass

4. STOCK OPTIONS (Details - Assumptions)	9 Months Ended
	Sep. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Dividends	0.00%
Volatility factor	156.00%
Expected life	10 years
Annual forfeiture rate	0.00%

4. STOCK OPTIONS (Details-Optio

4. STOCK OPTIONS (Details-Option activity) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2018	Dec. 31, 2017
Number of Shares
Outstanding, beginning balance	449,480,441
Granted	1,455,000,000
Exercised	0
Cancelled and forfeited	0
Outstanding, ending balance	1,904,480,441	449,480,441
Exercisable, ending balance	1,176,980,441
Weighted Average Exercise Price Per Share
Outstanding, beginning balance	$ 0.0026
Weighted average exercise price, granted	0.0008
Outstanding, ending balance	0.0012	$ 0.0026
Exercisable, ending balance	$ 0.0015
Weighted Average Remaining Contractual Terms in Years
Weighted average remaining contractual term, outstanding	9 years 3 months 15 days	8 years 3 months 11 days
Weighted average remaining contractual term, granted	9 years 10 months 3 days
Weighted average remaining contractual term, exercisable	9 years 3 months 15 days
Aggregate Intrinsic Value
Outstanding, ending balance	$ 0
Exercisable, ending balance	$ 0

5. INVESTMENTS (Details Narrati

5. INVESTMENTS (Details Narrative) - USD ($)	Jul. 16, 2018	Sep. 30, 2018	Dec. 31, 2017	Jun. 01, 2017
Investment		$ 0	$ 6,000
Almaden Energy Group [Member]
Ownership interest before sale	18.75%
CMAC Agriculture [Member]
Equity investment percentage		3.375%
Vispace Callifornia [Member]
Equity investment percentage		18.75%
Dividends from equity investment		$ 0
Investment		$ 0
Minimum ownership percentage		50.00%
Clean Energy Solutions [Member]
Investment				$ 0
Cost method investment percentage				2.91%

6. CONVERTIBLE NOTES PAYABLE _2

6. CONVERTIBLE NOTES PAYABLE TO RELATED PARTIES (Details Narrative) - USD ($)	May 24, 2018	Jul. 25, 2017	Feb. 23, 2017	Nov. 30, 2016	Sep. 30, 2018
Haris Basit [Member]
Loan agreement maximum amount				$ 100,000
Debt maturity period				2 years
Loan will accrue interest rate, percentage				8.00%
Number of trading days				20 days
Loan discount percentage				80.00%
Proceeds from related party					$ 27,500
Discount on note due to beneficial conversion feature					27,500
Loans converted into shares, loan amount converted					$ 27,500
Loans converted into shares, shares issued					127,691,910
Convertible notes payable					$ 0
Remaining availability under the note					0
Debt, face amount				$ 100,000
Dr. Kevin Schewe [Member]
Debt maturity period			2 years
Loan will accrue interest rate, percentage			8.00%
Number of trading days			20 days
Loan discount percentage			80.00%
Proceeds from related party					56,000
Discount on note due to beneficial conversion feature					56,000
Loans converted into shares, loan amount converted					$ 56,000
Loans converted into shares, shares issued					353,351,835
Convertible notes payable					$ 0
Remaining availability under the note					64,000
Debt, face amount			$ 100,000
Debt, face amount under new loan agreement	$ 100,000
Debt maturity period under new loan agreement	2 years
Loan will accrue interest rate under new loan agreement, percentage	8.00%
Number of trading days under new loan agreement	20 days
Loan discount percentage under new loan agreement	80.00%
Dr. Kukkonen [Member]
Loan agreement maximum amount		$ 25,000
Debt maturity period		2 years
Loan will accrue interest rate, percentage		8.00%
Number of trading days		20 days
Loan discount percentage		80.00%
Proceeds from related party					0
Convertible notes payable					0
Remaining availability under the note					$ 13,500
Debt, face amount		$ 25,000

7. STOCKHOLDERS' EQUITY (Detail

7. STOCKHOLDERS' EQUITY (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Jun. 30, 2018	Jan. 01, 2018	Dec. 31, 2017
Preferred stock shares authorized	10,000,000				10,000,000
Preferred stock par value	$ 0.0001				$ 0.0001
Preferred stock shares outstanding	1				1
Common stock shares authorized	8,000,000,000		8,000,000,000	3,900,000,000	8,000,000,000
Common stock par value	$ 0.0001		$ 0.0001		$ 0.0001
Common stock, shares outstanding	3,787,958,192				3,302,514,447
Common stock, shares issued	3,887,958,192				3,402,514,447
Dr. Kevin Schewe [Member]
Loans converted into shares, shares issued	353,351,835
Haris Basit [Member]
Loans converted into shares, shares issued	127,691,910
Funding Source [Member]
Stock issued for future expenses, shares issued		50,000,000
Percentage of future expenses plus fee from funding source		15.00%
Consultant [Member]
Stock issued for services, shares	4,400,000
Stock issued for services, value	$ 3,000
Series A Preferred Stock [Member]
Preferred stock shares outstanding	1				1

8. NET LOSS PER SHARE (Details-

8. NET LOSS PER SHARE (Details-Equivalents) - shares	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Earnings Per Share [Abstract]
Common stock equivalents excluded from EPS	1,904,480,441	418,855,000

8. NET LOSS PER SHARE (Detail_2

8. NET LOSS PER SHARE (Details-EPS) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Basic and diluted net income (loss) per share:
Numerator : Net loss attributable to common stock	$ (451,000)	$ (294,000)	$ (632,000)	$ (796,000)
Denominator
Weighted average shares of common stock outstanding	3,860,988,342	3,237,284,099	3,677,586,487	3,051,228,069
Net loss per share of common stock, basic and diluted	$ 0	$ 0	$ 0	$ 0

9. RELATED PARTY TRANSACTIONS (

9. RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2017
Related party receivables	$ 2,000		$ 0
Related party payables	$ 749,000		749,000
Options granted	1,455,000,000
Viaspace California, Inc [Member]
Related party receivables	$ 2,000
Carl Kukkonen [Member]
Related party payables	689,000		$ 689,000
Related party cash payable	185,000
Related party common stock payable, value	504,000
Additional related party payables	$ 2,000
Options granted	150,000,000
Carl Kukkonen [Member] | 2009 Deferred [Member]
Shares for deferred compensation	11,195,707
Carl Kukkonen [Member] | 2010 Deferred [Member]
Shares for deferred compensation	8,467,939
Carl Kukkonen [Member] | 2011 Deferred [Member]
Shares for deferred compensation	24,730,678
Harris Basit [Member]
Salary payable	$ 60,000
Additional related party payables	$ 18,000
Options granted	500,000,000	37,500,000
Nicholas Stoll [Member]
Additional related party payables	$ 9,000
Options granted	100,000,000
Dr. Kevin Schewe [Member]
Options granted	350,000,000
Ms Angelina Galiteva
Options granted	10,000,000

10. COMMITMENTS AND CONTINGEN_2

10. COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Commitments And Contingencies Disclosure [Abstract]
Rent Expense	$ 0	$ 4,000	$ 0	$ 9,000
Revenue received from collaborative agreements	$ 0	$ 0	20,000	0
Revenue recognized from collaborative agreements			$ 13,846	$ 0

11. SUBSEQUENT EVENTS (Details

11. SUBSEQUENT EVENTS (Details Narrative) - Consultant [Member] - USD ($)	Oct. 22, 2018	Sep. 30, 2018
Subsequent Event [Line Items]
Stock issued for services, shares		4,400,000
Stock issued for services, value		$ 3,000
Subsequent Events [Member]
Subsequent Event [Line Items]
Stock issued for services, shares	1,960,000
Stock issued for services, value	$ 1,000